Full Text View
Tabular View
No Study Results Posted
Related Studies
A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
This study has been completed.
Study NCT00097591   Information provided by Eli Lilly and Company
First Received: November 24, 2004   Last Updated: July 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Arteriosclerosis
Acute Coronary Syndrome
Additional conditions recognized in this trial
Arteriosclerosis
Coronary Artery Disease
Syndrome
More general conditions related to this trial
Arterial Occlusive Diseases
Cardiovascular Diseases
Coronary Disease
Disease
Heart Diseases
Myocardial Ischemia
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Prasugrel
Clopidogrel
More general drug interventions related to this trial
Hematologic Agents
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services